A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma
Clinical trial NCT02372227 · TERMINATED
Trial details
- NCT number
- NCT02372227
- Sponsor
- Verastem, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.